Recruiting Parkinsons Disease Studies in Newport Beach
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population....
Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).
Subjects who completed either OBERON or TITANIA will be offered the opportunity to consent for this Multicentre, Double-blind, Randomised, Placebo controlled, Parallel Group, Phase 3, extension study ...
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
This Phase IIb dose-ranging study will evaluate the efficacy and safety of 3 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe chronic obstructive p...
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive...
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Solrikitug in Participants with Chronic Obstru...
About Parkinsons Disease Clinical Trials in Newport Beach
Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.
There are currently 5 parkinsons disease clinical trials recruiting participants in Newport Beach, CA. These studies are seeking a combined 8,170 participants. Research is being sponsored by Chiesi Farmaceutici S.p.A., AstraZeneca, Uniquity One (UNI). Clinical trial participation is free and participants receive study-related medical care at no cost.
Parkinsons Disease Clinical Trials in Newport Beach — FAQ
Are there parkinsons disease clinical trials in Newport Beach?
Yes, there are 5 parkinsons disease clinical trials currently recruiting in Newport Beach, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Newport Beach?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newport Beach research site will contact you about next steps.
Are clinical trials in Newport Beach free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newport Beach studies also compensate for your time and travel.
What parkinsons disease treatments are being tested?
The 5 active trials in Newport Beach are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.
Data updated March 2, 2026 from ClinicalTrials.gov